ProductDescription
SU-11274isanoxindole-based,ATP-competitive,Metinhibitorwithactivityof20nMandis>500-foldselectiveagainstavarietyofotherkinasessuchasPDGFR,EGFR,cdk2,src,andFGFR.[1]SU11274inducesG1cellcyclearrestandapoptosiswithincreasedcaspase3activity.ReductionofphosphorylationinthePI3KandRaspathwaycomponents,suchasAkt,GSK-3,andFKHR.[1]SU11274inhibitscellviABIlity,c-Met/HGFanddownstreamcellproliferationinc-Met-expressingNSCLCcells.[2]
Morerecently,SU11274hasbeenextensivelystudiedforthetreatmentofhepatocellularcarcinoma(HCC).Inparticular,cellspostiivefordes-gamma-carboxyprothrombin(DCP),anagentthatinteractswithc-MettoactivateHCCcellgrowth,wereinhibitedbySU11274.[3]
Technicalinformation:
ChemicalFormula: | C28H30CIN5O4S | |
CAS#: | 658084-23-2 | |
MolecularWeight: | 568.09 | |
Purity: | >98% | |
Appearance: | Yellow | |
ChemicalName: | (Z)-N-(3-chlorophenyl)-3-((3,5-dimethyl-4-(1-methylpiperazine-4-carbonyl)-1H-pyrrol-2-yl)methylene)-N-methyl-2-oxoindoline-5-sulfonamide | |
Solubility: | Upto100mMinDMSO | |
Synonyms: | SU11274,SU-11274 |
ShippingCondition:Theproductisshippedinaglassvialatambienttemperature.
Storagecondition:Forlongershelflife,storesolidpowderat4oCdesiccated,orstoreDMSOsolutionat-20oC.
Reference:
1. | Sattleretal.,AnovelsmallmoleculemetinhibitorinducesapoptosisincellstransformedbytheoncogenicTPR-METtyrosinekinase.CancerRes.2003,63,5462-5469.PubmedID:14500382 |
2. | Maetal.,Functionalexpressionandmutationsofc-MetanditstherapeuticinhibitionwithSU11274andsmallinterferingRNAinnon-smallcelllungcancer.CancerRes.2005,65,1479-1488.PubmedID:15735036 |
3. | Inagakietal.,Effectofc-MetinhibitorSU11274onhepatocellularcarcinomacellgrowth.BioScienceTrends2011,5(2),52-56.PubmedID:21572247 |
Cellagen的ChamQ SYBR qPCR预混液(无ROX)| Q321产品描述ChamQSYBR®qPCR预混液(Vazyme,#Q321)由香槟Taq DNA聚合酶(Vazyme,#P122)通过抗体修饰的热启动激活技术保护,是专为基于SYBR Green I的定量PCR(qPCR)设计的。ChamQSYBR®qPCR Master Mix的优化缓冲液系统中的独特因素(即促进特异性的Exactor)大大提高了其灵敏度和特异性。该混合物以2倍反应浓度制备,可直接用于鲁棒性低模板qPCR,具有高灵敏度,特异性和可靠性。优点特异性+敏感性的最佳组合。独特的抗体修饰的热启动taq,具有独特的特异性促进因子。Mg2 +和染料的最佳浓度。